Discover trends, market shifts, and competitive outlooks for the adult vaccines industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#What Are the Key Milestones in the Adult Vaccines Market’s Growth Trajectory From 2025 To 2034?

The market size for adult vaccines has made robust growth of late. It is projected to escalate from $22.82 billion in 2024 to $24.49 billion in 2025, at a Compound Annual Growth Rate (CAGR) of 7.3%. The notable growth in the previous period is primarily due to factors such as the growing aging population, governmental vaccination initiatives, rising acknowledgement of preventive healthcare, advancements in vaccine development and innovation, as well as public health promotion campaigns.

The market size for adult vaccines is anticipated to witness robust expansion in the upcoming years, with a projected size of $35.22 billion in 2029 and an expected compound annual growth rate (CAGR) of 9.5%. The predicted growth during the forecast period can be associated with factors such as the rise in new infectious diseases, amplified attention on immunization databases, escalating concerns over antimicrobial resistance, international actions towards pandemic readiness, transition to personalized vaccines, and an intensified emphasis on maternal immunization. Noteworthy trends in the forecast period encompass the incorporation of digital health services, technological progress in vaccine manufacturing, partnerships among governments and pharmaceutical firms, enhancements in vaccine delivery mechanisms, and broadening immunization initiatives.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9038&type=smp

Which Factors and External Forces Are Driving Demand in the Adult Vaccines Market?

The escalating occurrence of communicable diseases is propelling progress in the adult vaccine market. Person-to-person transmission characterizes these types of diseases. Vaccinations serve to build a person’s immunity against these communicable diseases, making them an incredibly efficient weapon against infection. For example, the Centers for Disease Control and Prevention, a public health agency based in the US, reported in March 2023 that there were 8,300 cases of tuberculosis in the United States in 2022, a rise from 7,874 in the preceding year. The incidence rate of TB saw a mild increment in 2022, witnessing 2.5 reported cases per 100,000 inhabitants, a slight rise from 2.4 in 2021. Consequently, the escalating occurrence of communicable diseases steers the expansion of the adult vaccine market.

Which Segments in the Adult Vaccines Offer the Most Growth?

The adult vaccines market covered in this report is segmented –

1) By Vaccine Type: Monovalent, Multivalent

2) By Technology: Live Attenuated Vaccines, Inactivated Viral Or Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines

3) By Application: Influenza, DPT, Human Papillomavirus, Zoster, Pneumococcal, Hepatitis

4) By End Users: Healthcare Firms, Hospitals

Subsegments:

1) By Monovalent: Single Antigen Vaccines, Specific Disease Vaccines

2) By Multivalent: Combination Vaccines, Multi-Antigen Vaccines

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=9038&type=smp

What Are the Fastest-Growing Geographies in the Adult Vaccines Market?

North America was the largest region in the adult vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the adult vaccines market during the forecast period. The regions covered in the adult vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Which Cutting-Edge Market Trends Are Expected to Drive theAdult Vaccines Market’s Growth?

The emergence of innovative products is a considerable trend becoming prominent in the adult vaccines market. To maintain a competitive edge, dominant companies are focusing on the development and rollout of inventive products. As an illustration, GSK, a biopharmaceutical company from the UK, along with IQVIA, an international company from India known for providing advanced analytics, technology solutions, and clinical research services, initiated the launch of Vaccine Track in August 2022. Vaccine Track, a platform for analyzing vaccine data trends, aims to bolster adult vaccination across various communities. This tool is designed to supply frequent and pertinent insights about trends, thereby refining focus areas and bolstering public health initiatives.

View the full report here:

https://www.thebusinessresearchcompany.com/report/adult-vaccines-global-market-report

What Are the Key Elements That Define the Adult Vaccines Market?

Adult vaccines refer to the vaccines that are used to induce an immune response against a disease causing pathogen in adults. These vaccines are used for preventing and treating diseases. Vaccines lessen the severity of illness in individuals who are more vulnerable, such as those with chronic health conditions or weakened immune systems.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9038

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model